Your email has been successfully added to our mailing list.

×
0 0.000865800865800847 0.000865800865800847 0.000865800865800847 0.000865800865800847 0.000744588744588701 0.000744588744588701 0.000744588744588701
Stock impact report

Inflation Reduction Act: A Bullish Catalyst For Viatris Inc. [Seeking Alpha]

Viatris Inc. (VTRS) 
Company Research Source: Seeking Alpha
The shortened exclusivity period may create a bullish catalyst for certain stocks in the generic pharmaceutical sector. Gilead will face a patent "mini-cliff" in the near future, providing opportunities for generic drug manufacturers. A unique opportunity presents itself for lesser known Viatris. The Inflation Reduction Act ('IRA'), enacted in August 2022, focused on several key areas. The legislation is very extensive and complex. This article will focus specifically on healthcare and the ramifications for generic pharmaceutical companies in the healthcare sector: Recommended For You Recommended For You Show less Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for VTRS alerts
Opt-in for
VTRS alerts

from News Quantified
Opt-in for
VTRS alerts

from News Quantified